Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ALBEMARLE CORPALB · Entity 2581 | Director · Chairman & CEO | May 15, 2026 | May 19, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ALBEMARLE CORP
Report date May 15, 2026 · Filed May 19, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 87,519 |
Ending reported balance
After 2026-05-15 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2026-05-15 · Sale · Disposed 3,826 · Balance 100,086 F1: The price reported in Column 4 is a weighted average price. These shares were sold by the reporting person for diversification and tax planning purposes in multiple transactions, at prices ranging from $182.415 to $183.41, inclusive. The reporting person undertakes to provide to Albemarle Corporation, any security holder of Albemarle Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 2 · 2026-05-15 · Sale · Disposed 11,867 · Balance 88,219 F2: The price reported in Column 4 is a weighted average price. These shares were sold by the reporting person for diversification and tax planning purposes in multiple transactions, at prices ranging from $183.42 to $184.40, inclusive. The reporting person undertakes to provide to Albemarle Corporation, any security holder of Albemarle Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 3 · 2026-05-15 · Sale · Disposed 700 · Balance 87,519 F3: The price reported in Column 4 is a weighted average price. These shares were sold by the reporting person for diversification and tax planning purposes in multiple transactions, at prices ranging from $184.43 to $184.54, inclusive. The reporting person undertakes to provide to Albemarle Corporation, any security holder of Albemarle Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reporting person retains significant holdings in Albemarle stock, in excess of his required holdings under Albemarle stock ownership guidelines. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were sold by the reporting person for diversification and tax planning purposes in multiple transactions, at prices ranging from $182.415 to $183.41, inclusive. The reporting person undertakes to provide to Albemarle Corporation, any security holder of Albemarle Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2: The price reported in Column 4 is a weighted average price. These shares were sold by the reporting person for diversification and tax planning purposes in multiple transactions, at prices ranging from $183.42 to $184.40, inclusive. The reporting person undertakes to provide to Albemarle Corporation, any security holder of Albemarle Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3: The price reported in Column 4 is a weighted average price. These shares were sold by the reporting person for diversification and tax planning purposes in multiple transactions, at prices ranging from $184.43 to $184.54, inclusive. The reporting person undertakes to provide to Albemarle Corporation, any security holder of Albemarle Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reporting person retains significant holdings in Albemarle stock, in excess of his required holdings under Albemarle stock ownership guidelines.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 15, 2026 Filed May 19, 2026 20:37 UTC | ALBEMARLE CORP ALB · Entity 2581 | SaleCommon Stock | 700 | $184.52 | $129,164.00 |
DisclosureSEC source: 0000915913-26-000080 · wk-form4_1779223048.xml · nonDerivative · entry 3 Masters J Kent · CIK 0001396415 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,519 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold by the reporting person for diversification and tax planning purposes in multiple transactions, at prices ranging from $184.43 to $184.54, inclusive. The reporting person undertakes to provide to Albemarle Corporation, any security holder of Albemarle Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reporting person retains significant holdings in Albemarle stock, in excess of his required holdings under Albemarle stock ownership guidelines. Read SEC document |
| May 15, 2026 Filed May 19, 2026 20:37 UTC | ALBEMARLE CORP ALB · Entity 2581 | SaleCommon Stock | 11,867 | $183.87 | $2,181,985.29 |
DisclosureSEC source: 0000915913-26-000080 · wk-form4_1779223048.xml · nonDerivative · entry 2 Masters J Kent · CIK 0001396415 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,219 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold by the reporting person for diversification and tax planning purposes in multiple transactions, at prices ranging from $183.42 to $184.40, inclusive. The reporting person undertakes to provide to Albemarle Corporation, any security holder of Albemarle Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 15, 2026 Filed May 19, 2026 20:37 UTC | ALBEMARLE CORP ALB · Entity 2581 | SaleCommon Stock | 3,826 | $183.12 | $700,617.12 |
DisclosureSEC source: 0000915913-26-000080 · wk-form4_1779223048.xml · nonDerivative · entry 1 Masters J Kent · CIK 0001396415 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,086 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold by the reporting person for diversification and tax planning purposes in multiple transactions, at prices ranging from $182.415 to $183.41, inclusive. The reporting person undertakes to provide to Albemarle Corporation, any security holder of Albemarle Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 12, 2026 Filed Mar 12, 2026 22:49 UTC | ALBEMARLE CORP ALB · Entity 2581 | GiftCommon Stock | 30,716 | $162.79 | $5,000,257.64 |
DisclosureSEC source: 0001396415-26-000010 · wk-form4_1773355784.xml · nonDerivative · entry 4 Masters J Kent · CIK 0001396415 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 103,912 F4 · price: For tax and estate planning purposes, these shares were transferred to an irrevocable trust over which the reporting person has no influence or control. The reporting person retains significant holdings in Albemarle stock, in excess of his required holdings under Albemarle stock ownership guidelines. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 22:49 UTC | ALBEMARLE CORP ALB · Entity 2581 | SaleCommon Stock | 996 | $171.82 | $171,132.72 |
DisclosureSEC source: 0001396415-26-000010 · wk-form4_1773355784.xml · nonDerivative · entry 3 Masters J Kent · CIK 0001396415 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 134,628 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold by the reporting person for diversification and tax planning purposes in multiple transactions, at prices ranging from $171.67 to $171.89, inclusive. The reporting person undertakes to provide to Albemarle Corporation, any security holder of Albemarle Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reporting person retains significant holdings in Albemarle stock, in excess of his required holdings under Albemarle stock ownership guidelines. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 22:49 UTC | ALBEMARLE CORP ALB · Entity 2581 | SaleCommon Stock | 5,392 | $171.18 | $923,002.56 |
DisclosureSEC source: 0001396415-26-000010 · wk-form4_1773355784.xml · nonDerivative · entry 2 Masters J Kent · CIK 0001396415 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 135,624 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold by the reporting person for diversification and tax planning purposes in multiple transactions, at prices ranging from $170.63 to $171.57, inclusive. The reporting person undertakes to provide to Albemarle Corporation, any security holder of Albemarle Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reporting person retains significant holdings in Albemarle stock, in excess of his required holdings under Albemarle stock ownership guidelines. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 22:49 UTC | ALBEMARLE CORP ALB · Entity 2581 | SaleCommon Stock | 5,395 | $170.26 | $918,552.70 |
DisclosureSEC source: 0001396415-26-000010 · wk-form4_1773355784.xml · nonDerivative · entry 1 Masters J Kent · CIK 0001396415 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 141,016 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold by the reporting person for diversification and tax planning purposes in multiple transactions, at prices ranging from $169.63 to $170.62, inclusive. The reporting person undertakes to provide to Albemarle Corporation, any security holder of Albemarle Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reporting person retains significant holdings in Albemarle stock, in excess of his required holdings under Albemarle stock ownership guidelines. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 23:28 UTC | ALBEMARLE CORP ALB · Entity 2581 | GrantCommon Stock | 22,450 | $0.00 | $0.00 |
DisclosureSEC source: 0001396415-26-000006 · wk-form4_1772666917.xml · nonDerivative · entry 1 Masters J Kent · CIK 0001396415 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 146,411 F1 · shares: Restricted Stock Units vest 100% on 03/30/2027, subject to the terms of the award agreement. Read SEC document |
| February 26, 2026 Filed Mar 2, 2026 22:12 UTC | ALBEMARLE CORP ALB · Entity 2581 | Tax withholdingCommon Stock | 3,924 | $184.93 | $725,665.32 |
DisclosureSEC source: 0001396415-26-000003 · wk-form4_1772489546.xml · nonDerivative · entry 2 Masters J Kent · CIK 0001396415 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123,961 F2 · shares: Shares withheld to meet tax liabilities associated with vesting of Performance Stock Units granted on 02/24/2023 Read SEC document |
| February 26, 2026 Filed Mar 2, 2026 22:12 UTC | ALBEMARLE CORP ALB · Entity 2581 | GrantCommon Stock | 9,032 | $184.93 | $1,670,287.76 |
DisclosureSEC source: 0001396415-26-000003 · wk-form4_1772489546.xml · nonDerivative · entry 1 Masters J Kent · CIK 0001396415 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 127,885 F1 · shares: Performance Stock Units granted 02/24/2023. 50% granted as ROIC Performance Stock Units and 50% granted as rTSR Performance Stock Units. Based on the performance multiplier, no shares were earned for the ROIC Performance Stock Units. For the rTSR Performance Stock Units, all shares earned vested on 2/26/2026. Read SEC document |
| December 31, 2025 Filed Jan 2, 2026 21:13 UTC | ALBEMARLE CORP ALB · Entity 2581 | Tax withholdingCommon Stock | 13,835 | $141.44 | $1,956,822.40 |
DisclosureSEC source: 0000915913-26-000003 · wk-form4_1767388384.xml · nonDerivative · entry 3 Masters J Kent · CIK 0001396415 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 118,853 F3 · shares: Shares withheld to meet tax liabilities associated with vesting of RSUs granted on 02/27/2025. Read SEC document |
| December 31, 2025 Filed Jan 2, 2026 21:13 UTC | ALBEMARLE CORP ALB · Entity 2581 | Tax withholdingCommon Stock | 9,245 | $141.44 | $1,307,612.80 |
DisclosureSEC source: 0000915913-26-000003 · wk-form4_1767388384.xml · nonDerivative · entry 2 Masters J Kent · CIK 0001396415 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 132,688 F2 · shares: Shares withheld to meet tax liabilities associated with vesting of RSUs granted on 02/22/2024. Read SEC document |
| December 31, 2025 Filed Jan 2, 2026 21:13 UTC | ALBEMARLE CORP ALB · Entity 2581 | Tax withholdingCommon Stock | 4,379 | $141.44 | $619,365.76 |
DisclosureSEC source: 0000915913-26-000003 · wk-form4_1767388384.xml · nonDerivative · entry 1 Masters J Kent · CIK 0001396415 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 141,933 F1 · shares: Shares withheld to meet tax liabilities associated with vesting of Restricted Stock Units (RSUs) granted on 02/24/2023. Read SEC document |
| February 27, 2025 Filed Feb 28, 2025 22:30 UTC | ALBEMARLE CORP ALB · Entity 2581 | Exercise / conversionPerformance Stock Units · Derivative | 16,932 | $0.00 | $0.00 |
DisclosureSEC source: 0000915913-25-000044 · wk-form4_1740781834.xml · derivative · entry 3 Masters J Kent · CIK 0001396415 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,932 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each Performance Stock Unit converts to 1 share of Common Stock. F1 · shares: Adjusted ROIC Performance Stock Units granted on 02/25/2022. Payout based on 200% performance multiplier. All shares earned vested on 02/27/2025. F4 · derivative.expiration_date: No expiration date. Read SEC document |
| February 27, 2025 Filed Feb 28, 2025 22:30 UTC | ALBEMARLE CORP ALB · Entity 2581 | Tax withholdingCommon Stock | 7,442 | $78.97 | $587,694.74 |
DisclosureSEC source: 0000915913-25-000044 · wk-form4_1740781834.xml · nonDerivative · entry 2 Masters J Kent · CIK 0001396415 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 114,654 F2 · shares: Shares withheld to meet tax liabilities associated with vesting of Performance Stock Units. Read SEC document |
| February 27, 2025 Filed Feb 28, 2025 22:30 UTC | ALBEMARLE CORP ALB · Entity 2581 | Exercise / conversionCommon Stock | 16,932 | $0.00 | $0.00 |
DisclosureSEC source: 0000915913-25-000044 · wk-form4_1740781834.xml · nonDerivative · entry 1 Masters J Kent · CIK 0001396415 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 122,096 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Adjusted ROIC Performance Stock Units granted on 02/25/2022. Payout based on 200% performance multiplier. All shares earned vested on 02/27/2025. Read SEC document |
| February 27, 2025 Filed Mar 3, 2025 23:23 UTC | ALBEMARLE CORP ALB · Entity 2581 | GrantStock Options · Derivative | 73,965 | $0.00 Strike: $78.97 | $0.00 |
DisclosureSEC source: 0000915913-25-000059 · wk-form4_1741044212.xml · derivative · entry 2 Masters J Kent · CIK 0001396415 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,965 Underlying: Common Stock · 73,965 shares Expires 2035-02-27 F2 · derivative.exercise_date: Stock Options vest and become exercisable on the earlier of 12/31/2025 or the date a successor Chief Executive Officer commences employment with the Issuer. Read SEC document |
| February 27, 2025 Filed Mar 3, 2025 23:23 UTC | ALBEMARLE CORP ALB · Entity 2581 | GrantCommon Stock | 31,658 | $0.00 | $0.00 |
DisclosureSEC source: 0000915913-25-000059 · wk-form4_1741044212.xml · nonDerivative · entry 1 Masters J Kent · CIK 0001396415 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 146,312 F1 · shares: Restricted Stock Units vest 100% on the earlier of 12/31/2025 or the date a successor Chief Executive Officer commences employment with the Issuer. Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 21:12 UTC | ALBEMARLE CORP ALB · Entity 2581 | Exercise / conversionRestricted Stock Units · Derivative | 434 | $0.00 | $0.00 |
DisclosureSEC source: 0000915913-25-000007 · wk-form4_1735938725.xml · derivative · entry 3 Masters J Kent · CIK 0001396415 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 434 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU converts to 1 share of Common Stock. F4 · derivative.exercise_date: RSUs granted on 02/25/2022. 95% vested on 12/31/2023 and remaining 5% vested on 12/31/2024. F5 · derivative.expiration_date: No expiration date. Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 21:12 UTC | ALBEMARLE CORP ALB · Entity 2581 | Tax withholdingCommon Stock | 192 | $86.08 | $16,527.36 |
DisclosureSEC source: 0000915913-25-000007 · wk-form4_1735938725.xml · nonDerivative · entry 2 Masters J Kent · CIK 0001396415 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,164 F2 · shares: Shares withheld to meet tax liabilities associated with vesting of RSUs. F1 · balance_after: The Reporting Person's holdings reported in Table 1, Column 5 include: 10,020 Restricted Stock Units ("RSUs") granted on February 24, 2023, and 21,155 RSUs granted on February 22, 2024, which were previously reported in Table 2 in Forms 4 filed 2/28/2023 and 2/26/2024, respectively. These RSUs will vest 100% on the earlier of 12/31/2025 or the date a successor Chief Executive Officer commences employment with the Issuer (subject to the terms of the applicable award agreement). Starting with this report, RSUs subject to time-based vesting conditions will be reported in Table 1 at grant and in Column 5 as beneficially owned for consistency in reporting methodology amongst reporting persons of the Issuer. Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 21:12 UTC | ALBEMARLE CORP ALB · Entity 2581 | Exercise / conversionCommon Stock | 434 | $0.00 | $0.00 |
DisclosureSEC source: 0000915913-25-000007 · wk-form4_1735938725.xml · nonDerivative · entry 1 Masters J Kent · CIK 0001396415 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,356 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: The Reporting Person's holdings reported in Table 1, Column 5 include: 10,020 Restricted Stock Units ("RSUs") granted on February 24, 2023, and 21,155 RSUs granted on February 22, 2024, which were previously reported in Table 2 in Forms 4 filed 2/28/2023 and 2/26/2024, respectively. These RSUs will vest 100% on the earlier of 12/31/2025 or the date a successor Chief Executive Officer commences employment with the Issuer (subject to the terms of the applicable award agreement). Starting with this report, RSUs subject to time-based vesting conditions will be reported in Table 1 at grant and in Column 5 as beneficially owned for consistency in reporting methodology amongst reporting persons of the Issuer. Read SEC document |
| December 05, 2024 Filed Dec 6, 2024 21:25 UTC | ALBEMARLE CORP ALB · Entity 2581 | SaleCommon Stock | 2,525 | $101.12 | $255,328.00 |
DisclosureSEC source: 0000915913-24-000168 · wk-form4_1733520335.xml · nonDerivative · entry 1 Masters J Kent · CIK 0001396415 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,747 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.04 to $101.19, inclusive. The reporting person undertakes to provide to Albemarle Corporation, any security holder of Albemarle Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 26, 2024 Filed Feb 28, 2024 22:38 UTC | ALBEMARLE CORP ALB · Entity 2581 | Tax withholdingCommon Stock | 3,496 | $121.52 | $424,833.92 |
DisclosureSEC source: 0000915913-24-000061 · wk-form4_1709159903.xml · nonDerivative · entry 2 Masters J Kent · CIK 0001396415 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,272 F2 · shares: Shares withheld to meet tax liabilities associated with vesting of Common Stock. Read SEC document |
| February 26, 2024 Filed Feb 28, 2024 22:38 UTC | ALBEMARLE CORP ALB · Entity 2581 | GrantCommon Stock | 7,908 | $0.00 | $0.00 |
DisclosureSEC source: 0000915913-24-000061 · wk-form4_1709159903.xml · nonDerivative · entry 1 Masters J Kent · CIK 0001396415 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,768 F1 · shares: Shares were issued to the Reporting Person on 2/26/2024 as settlement of 50% of the payout earned under the Issuer's 2023 Annual Incentive Plan and vested immediately. Read SEC document |
| February 22, 2024 Filed Feb 27, 2024 01:45 UTC | ALBEMARLE CORP ALB · Entity 2581 | GrantStock Options · Derivative | 51,335 | $0.00 Strike: $118.18 | $0.00 |
DisclosureSEC source: 0000915913-24-000030 · wk-form4_1708998295.xml · derivative · entry 5 Masters J Kent · CIK 0001396415 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,335 Underlying: Common Stock · 51,335 shares Expires 2034-02-22 F7 · derivative.exercise_date: Stock Options vest on the earlier of 12/31/2025 or the date a successor Chief Executive Officer commences employment with the Issuer. Read SEC document |
| February 22, 2024 Filed Feb 27, 2024 01:45 UTC | ALBEMARLE CORP ALB · Entity 2581 | GrantRestricted Stock Units · Derivative | 21,155 | $0.00 | $0.00 |
DisclosureSEC source: 0000915913-24-000030 · wk-form4_1708998295.xml · derivative · entry 4 Masters J Kent · CIK 0001396415 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,155 Underlying: Common Stock · 21,155 shares Expires not disclosed F5 · derivative.exercise_price: Each Restricted Stock Unit converts to 1 share of Common Stock. F6 · derivative.exercise_date: Restricted Stock Units vest 100% on the earlier of 12/31/2025 or the date a successor Chief Executive Officer commences employment with the Issuer. F4 · derivative.expiration_date: No expiration date. Read SEC document |
| February 22, 2024 Filed Feb 27, 2024 01:45 UTC | ALBEMARLE CORP ALB · Entity 2581 | Exercise / conversionPerformance Stock Units · Derivative | 17,496 | $0.00 | $0.00 |
DisclosureSEC source: 0000915913-24-000030 · wk-form4_1708998295.xml · derivative · entry 3 Masters J Kent · CIK 0001396415 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,496 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each Performance Stock Unit converts into 1 share of Common Stock. F1 · derivative.exercise_date: Adjusted ROIC Performance Stock Units granted on 02/26/2021. Payout based on 200% performance multiplier and all units vested on 02/22/2024. Threshold performance was not achieved under the terms of the rTSR Performance Stock Units also granted on 02/26/2021 and no Common Stock was earned or paid under this grant. F4 · derivative.expiration_date: No expiration date. Read SEC document |
| February 22, 2024 Filed Feb 27, 2024 01:45 UTC | ALBEMARLE CORP ALB · Entity 2581 | Tax withholdingCommon Stock | 6,464 | $118.18 | $763,915.52 |
DisclosureSEC source: 0000915913-24-000030 · wk-form4_1708998295.xml · nonDerivative · entry 2 Masters J Kent · CIK 0001396415 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,860 F2 · shares: Shares withheld to meet tax liabilities associated with vesting of Performance Stock Units. Read SEC document |
| February 22, 2024 Filed Feb 27, 2024 01:45 UTC | ALBEMARLE CORP ALB · Entity 2581 | Exercise / conversionCommon Stock | 17,496 | $0.00 | $0.00 |
DisclosureSEC source: 0000915913-24-000030 · wk-form4_1708998295.xml · nonDerivative · entry 1 Masters J Kent · CIK 0001396415 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,324 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Adjusted ROIC Performance Stock Units granted on 02/26/2021. Payout based on 200% performance multiplier and all units vested on 02/22/2024. Threshold performance was not achieved under the terms of the rTSR Performance Stock Units also granted on 02/26/2021 and no Common Stock was earned or paid under this grant. Read SEC document |
| December 31, 2023 Filed Jan 4, 2024 01:12 UTC | ALBEMARLE CORP ALB · Entity 2581 | Exercise / conversionRestricted Stock Units · Derivative | 8,748 | $0.00 | $0.00 |
DisclosureSEC source: 0000915913-24-000010 · wk-form4_1704330709.xml · derivative · entry 4 Masters J Kent · CIK 0001396415 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,748 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit converts to 1 share of Common Stock. F5 · derivative.exercise_date: Restricted Stock Units granted on 02/26/2021 and vested on 12/31/2023. F4 · derivative.expiration_date: No expiration date. Read SEC document |
| December 31, 2023 Filed Jan 4, 2024 01:12 UTC | ALBEMARLE CORP ALB · Entity 2581 | Exercise / conversionRestricted Stock Units · Derivative | 8,032 | $0.00 | $0.00 |
DisclosureSEC source: 0000915913-24-000010 · wk-form4_1704330709.xml · derivative · entry 3 Masters J Kent · CIK 0001396415 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 434 Underlying: Common Stock · 8,032 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit converts to 1 share of Common Stock. F3 · derivative.exercise_date: Restricted Stock Units granted on 02/25/2022. 95% vested on 12/31/2023 and 5% vests on 12/31/2024. F4 · derivative.expiration_date: No expiration date. Read SEC document |
| December 31, 2023 Filed Jan 4, 2024 01:12 UTC | ALBEMARLE CORP ALB · Entity 2581 | Tax withholdingCommon Stock | 7,418 | $144.48 | $1,071,752.64 |
DisclosureSEC source: 0000915913-24-000010 · wk-form4_1704330709.xml · nonDerivative · entry 2 Masters J Kent · CIK 0001396415 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,828 F1 · shares: Shares withheld to meet tax liabilities associated with vesting of Restricted Stock Units. Read SEC document |
| December 31, 2023 Filed Jan 4, 2024 01:12 UTC | ALBEMARLE CORP ALB · Entity 2581 | Exercise / conversionCommon Stock | 16,780 | $0.00 | $0.00 |
DisclosureSEC source: 0000915913-24-000010 · wk-form4_1704330709.xml · nonDerivative · entry 1 Masters J Kent · CIK 0001396415 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,246 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 05, 2023 Filed May 8, 2023 20:49 UTC | ALBEMARLE CORP ALB · Entity 2581 | PurchaseCommon Stock | 5,470 | $181.64 | $993,570.80 |
DisclosureSEC source: 0000915913-23-000119 · wf-form4_168357893155684.xml · nonDerivative · entry 1 Masters J Kent · CIK 0001396415 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,466 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $181.11 to $182.06, inclusive. The reporting person undertakes to provide to Albemarle Corporation, any security holder of Albemarle Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 19, 2023 Filed Apr 21, 2023 20:40 UTC | ALBEMARLE CORP ALB · Entity 2581 | Exercise / conversionRestricted Stock Units · Derivative | 54,475 | $0.00 | $0.00 |
DisclosureSEC source: 0000915913-23-000098 · wf-form4_168210959741142.xml · derivative · entry 3 Masters J Kent · CIK 0001396415 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 54,475 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts to 1 share of Common Stock. F2 · derivative.exercise_date: Restricted Stock Units granted 05/08/2020 and vested 04/19/2023. F3 · derivative.expiration_date: No expiration date. Read SEC document |
| April 19, 2023 Filed Apr 21, 2023 20:40 UTC | ALBEMARLE CORP ALB · Entity 2581 | Tax withholdingCommon Stock | 24,351 | $203.78 | $4,962,246.78 |
DisclosureSEC source: 0000915913-23-000098 · wf-form4_168210959741142.xml · nonDerivative · entry 2 Masters J Kent · CIK 0001396415 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,996 Read SEC document |
| April 19, 2023 Filed Apr 21, 2023 20:40 UTC | ALBEMARLE CORP ALB · Entity 2581 | Exercise / conversionCommon Stock | 54,475 | $0.00 | $0.00 |
DisclosureSEC source: 0000915913-23-000098 · wf-form4_168210959741142.xml · nonDerivative · entry 1 Masters J Kent · CIK 0001396415 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,347 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 24, 2023 Filed Mar 1, 2023 00:01 UTC | ALBEMARLE CORP ALB · Entity 2581 | GrantStock Options · Derivative | 25,340 | $0.00 Strike: $249.52 | $0.00 |
DisclosureSEC source: 0000915913-23-000064 · wf-form4_167762883732688.xml · derivative · entry 2 Masters J Kent · CIK 0001396415 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,340 Underlying: Common Stock · 25,340 shares Expires 2033-02-24 F4 · derivative.exercise_date: Stock Options vest the earlier of 12/31/2025 or the date a successor CEO commences employment as the Company's CEO. Read SEC document |
| February 24, 2023 Filed Mar 1, 2023 00:01 UTC | ALBEMARLE CORP ALB · Entity 2581 | GrantRestricted Stock Units · Derivative | 10,020 | $0.00 | $0.00 |
DisclosureSEC source: 0000915913-23-000064 · wf-form4_167762883732688.xml · derivative · entry 1 Masters J Kent · CIK 0001396415 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,020 Underlying: Common Stock · 10,020 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit converts to 1 share of Common Stock. F2 · derivative.exercise_date: Restricted Stock Units vest the earlier of 12/31/2025 or the date a successor CEO commences employment as the Company's CEO. F3 · derivative.expiration_date: No expiration date. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 22:30 UTC | ALBEMARLE CORP ALB · Entity 2581 | GrantStock Options · Derivative | 25,794 | $0.00 Strike: $191.95 | $0.00 |
DisclosureSEC source: 0000915913-22-000073 · wf-form4_164617381816856.xml · derivative · entry 2 Masters J Kent · CIK 0001396415 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,794 Underlying: Common Stock · 25,794 shares Expires 2032-02-25 Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 22:30 UTC | ALBEMARLE CORP ALB · Entity 2581 | GrantRestricted Stock Units · Derivative | 8,466 | $0.00 | $0.00 |
DisclosureSEC source: 0000915913-22-000073 · wf-form4_164617381816856.xml · derivative · entry 1 Masters J Kent · CIK 0001396415 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,466 Underlying: Common Stock · 8,466 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit converts to 1 share of Common Stock. F2 · derivative.exercise_date: Restricted Stock Units vest on 02/25/2025. F3 · derivative.expiration_date: No expiration date. Read SEC document |
| February 18, 2022 Filed Feb 18, 2022 21:27 UTC | ALBEMARLE CORP ALB · Entity 2581 | PurchaseCommon Stock | 5,241 | $190.80 | $999,982.80 |
DisclosureSEC source: 0000915913-22-000023 · wf-form4_164521960633749.xml · nonDerivative · entry 1 Masters J Kent · CIK 0001396415 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,872 Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 22:49 UTC | ALBEMARLE CORP ALB · Entity 2581 | GrantRestricted Stock Units · Derivative | 8,748 | $0.00 | $0.00 |
DisclosureSEC source: 0000915913-21-000065 · wf-form4_161472531546211.xml · derivative · entry 2 Masters J Kent · CIK 0001396415 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,748 Underlying: Common Stock · 8,748 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit converts to 1 share of Common Stock. F3 · derivative.exercise_date: Restricted Stock Units vest 50% on 02/26/2024 and 50% on 02/26/2025. F4 · derivative.expiration_date: No expiration date. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 22:49 UTC | ALBEMARLE CORP ALB · Entity 2581 | GrantStock Option · Derivative | 27,823 | $0.00 Strike: $157.21 | $0.00 |
DisclosureSEC source: 0000915913-21-000065 · wf-form4_161472531546211.xml · derivative · entry 1 Masters J Kent · CIK 0001396415 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,823 Underlying: Common Stock · 27,823 shares Expires 2031-02-26 F1 · derivative.exercise_date: Stock Options vest on 02/26/2024. Read SEC document |
| July 01, 2020 Filed Jul 2, 2020 21:12 UTC | ALBEMARLE CORP ALB · Entity 2581 | Disposition to issuerCommon Stock | 354 | $0.00 | $0.00 |
DisclosureSEC source: 0000915913-20-000121 · wf-form4_159372429108310.xml · nonDerivative · entry 1 Masters J Kent · CIK 0001396415 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,700 F1 · shares: Unvested restricted stock granted on July 1, 2019 forfeited under the terms of the 2013 Director Stock Compensation and Deferral Election Plan, as amended January 1, 2020. Read SEC document |
| July 01, 2020 Filed Mar 8, 2021 21:49 UTC Amendment | ALBEMARLE CORP ALB · Entity 2581 | Disposition to issuerCommon Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0000915913-21-000072 · wf-form4a_161524018088780.xml · nonDerivative · entry 1 Masters J Kent · CIK 0001396415 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,631 F1 · balance_after: This amendment reflects a correction to the number of shares of Common Stock beneficially owned by the reporting person. The reporting person previously transferred 6,263 shares of Common Stock to his spouse pursuant to a judicially entered domestic relations order. As a consequence, the reporting person no longer reports as beneficially owned by him such 6,263 shares or any other securities owned by his spouse. In addition, the total number of shares of Common Stock directly beneficially owned by the reporting person includes 194 shares held in a brokerage account which, because of an administrative error, have not been previously reported. Read SEC document |
| May 08, 2020 Filed May 11, 2020 20:24 UTC | ALBEMARLE CORP ALB · Entity 2581 | GrantRestricted Stock Units · Derivative | 54,475 | $0.00 | $0.00 |
DisclosureSEC source: 0000915913-20-000106 · wf-form4_158922865906855.xml · derivative · entry 1 Masters J Kent · CIK 0001396415 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,475 Underlying: Common Stock · 54,475 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit converts to 1 share of Common Stock. F2 · derivative.exercise_date: Award will vest on the earlier of (i) April 19, 2023 and (ii) the date the company appoints someone other than the reporting person as the company's Chief Executive Officer. F3 · derivative.expiration_date: No expiration date. Read SEC document |
| July 01, 2019 Filed Jul 3, 2019 21:46 UTC | ALBEMARLE CORP ALB · Entity 2581 | GrantCommon Stock | 1,850 | $0.00 | $0.00 |
DisclosureSEC source: 0000915913-19-000066 · wf-form4_156219034656650.xml · nonDerivative · entry 1 Masters J Kent · CIK 0001396415 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,054 F1 · shares: Shares represent an annual installment of non-employee director stock compensation pursuant to 2013 Stock Compensation and Deferral Election Plan for Non-Employee Directors of Albemarle Corporation. Shares to vest on July 1, 2020. Read SEC document |
| July 02, 2018 Filed Jul 5, 2018 18:51 UTC | ALBEMARLE CORP ALB · Entity 2581 | GrantCommon Stock | 1,400 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-019417 · doc4.xml · nonDerivative · entry 1 Masters J Kent · CIK 0001396415 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,204 F1 · shares: Shares represent an annual installment of non-employee director stock compensation pursuant to 2013 Stock Compensation and Deferral Election Plan for Non-Employee Directors of Albemarle Corporation. Shares to vest on July 2, 2019. Read SEC document |
| July 03, 2017 Filed Jul 5, 2017 22:38 UTC | ALBEMARLE CORP ALB · Entity 2581 | GrantCommon Stock | 1,150 | $0.00 | $0.00 |
DisclosureSEC source: 0001648210-17-000027 · primary_doc.xml · nonDerivative · entry 1 Masters J Kent · CIK 0001396415 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,804 F1 · shares: Shares represent an annual installment of non-employee director stock compensation pursuant to 2013 Stock Compensation and Deferral Election Plan for Non-Employee Directors of Albemarle Corporation. Shares to vest on July 3, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.